Abstract:BackgroundNewly recognized endemic foci for human babesiosis include Europe, where Ixodes ricinus, a vector for several species of Babesia, is the most commonly identified tick. Vector-based surveillance provides an early warning system for the emergence of human babesiosis, which is likely to be under-reported at emerging sites. In the present study, we set out to screen I. ricinus collected from Danish domestic dogs for Babesia, in order to identify whether humans in Denmark are exposed to the parasite.Findi… Show more
“…Although ticks have the potential to transmit many different viruses, most studies surveying tick-borne pathogens in Europe have focused on bacterial and/or parasitic pathogens. Numerous reports detailing parasitic or bacterial prevalence in either European ticks or animal reservoirs are published every year [19] , [20] , [21] , [22] , [23] . For viruses however, the situation is completely different.…”
Ticks transmit more pathogens—including bacteria, parasites and viruses—than any other arthropod vector. Although the epidemiological status of many tick-borne bacteria is very well characterized, tick-borne viruses are still relatively under-studied. Recently, several novel tick-borne viruses have been isolated from human febrile illnesses following tick bites, indicating the existence of other potential new and unknown tick-borne viruses. We used high-throughput sequencing to analyse the virome of Ixodes ricinus, the main vector of tick-borne pathogens in Europe. The majority of collected viral sequences were assigned to two potentially novel Nairovirus and Phlebovirus viruses, with prevalence rates ranging from 3.95% to 23.88% in adults and estimated to be between 0.14% and 72.16% in nymphs. These viruses could not be isolated from the brains of inoculated immunocompromised mice, perhaps indicating that they are unable to infect vertebrates. Within the I. ricinus virome, we also identified contigs with >90% identity to the known Eyach virus. Initially isolated in the 1980s, this virus was indirectly associated with human disease, but had never been extensively studied. Eyach virus prevalence varied between 0.07% and 5.26% in ticks from the French Ardennes and Alsace regions. Eyach virus was successfully isolated following intracerebral inoculation of immunocompromised mice with Eyach virus-positive tick extracts. This virus was also able to multiply and persist in the blood of immunocompetent mice inoculated by intraperitoneal injection, and caused brain infections in three of nine juveniles, without any obvious deleterious effects.
“…Although ticks have the potential to transmit many different viruses, most studies surveying tick-borne pathogens in Europe have focused on bacterial and/or parasitic pathogens. Numerous reports detailing parasitic or bacterial prevalence in either European ticks or animal reservoirs are published every year [19] , [20] , [21] , [22] , [23] . For viruses however, the situation is completely different.…”
Ticks transmit more pathogens—including bacteria, parasites and viruses—than any other arthropod vector. Although the epidemiological status of many tick-borne bacteria is very well characterized, tick-borne viruses are still relatively under-studied. Recently, several novel tick-borne viruses have been isolated from human febrile illnesses following tick bites, indicating the existence of other potential new and unknown tick-borne viruses. We used high-throughput sequencing to analyse the virome of Ixodes ricinus, the main vector of tick-borne pathogens in Europe. The majority of collected viral sequences were assigned to two potentially novel Nairovirus and Phlebovirus viruses, with prevalence rates ranging from 3.95% to 23.88% in adults and estimated to be between 0.14% and 72.16% in nymphs. These viruses could not be isolated from the brains of inoculated immunocompromised mice, perhaps indicating that they are unable to infect vertebrates. Within the I. ricinus virome, we also identified contigs with >90% identity to the known Eyach virus. Initially isolated in the 1980s, this virus was indirectly associated with human disease, but had never been extensively studied. Eyach virus prevalence varied between 0.07% and 5.26% in ticks from the French Ardennes and Alsace regions. Eyach virus was successfully isolated following intracerebral inoculation of immunocompromised mice with Eyach virus-positive tick extracts. This virus was also able to multiply and persist in the blood of immunocompetent mice inoculated by intraperitoneal injection, and caused brain infections in three of nine juveniles, without any obvious deleterious effects.
“…In Switzerland, the prevalence of 'Candidatus Neoehrlichia mikurensis' in I. ricinus was estimated to be 6.4% in the western region and 3.5-8% in the eastern region of the country (Lommano et al, 2012;Maurer et al, 2013). The bacterium has also been detected in ticks in other European countries, including Germany, the Netherlands and Austria and pathogen specific DNA was detected in ticks collected from Danish and German dogs (Schreiber et al, 2014;Stensvold et al, 2015). Rodents may serve as a reservoir for 'Candidatus Neoehrlichia mikurensis'.…”
'Candidatus Neoehrlichia mikurensis' is an emerging tick-borne zoonotic agent that primarily affects immunocompromised human patients. Dogs and foxes are frequently exposed to ticks, and both species are in close proximity to humans.
“…: 16.1% T. gondii: 23%) [14,13]. Interestingly, these pathogens have been found in I. ricinus collected in Poland [9] and Denmark [7]. Due to the larger sample size in this study, it is likely that the prevalence of these pathogens in I. ricinus from South Central and Southernmost Sweden and the Åland islands, Finland is considerably lower.…”
Section: Discussionmentioning
confidence: 69%
“…The lack of Bartonella in Norway [31] and Finland [32] supports that tick-borne Bartonella spp. might not tolerate the harsher climate in most of the Nordic countries compared to Denmark [7]. There are no previously published data on the prevalence of T. gondii in neither blood-feeding nor questing ticks from the Nordic countries.…”
Section: Discussionmentioning
confidence: 97%
“…These pathogens have been detected within Ixodes ricinus in neighboring countries (Table 1) such as Germany (F. tularensis) [6], Denmark (Bartonella spp.) [7] and Poland (T. gondii) [8,9]. Since infection with F. tularensis subspecies (ssp.)…”
A milder climate has during the last decade contributed to an increased density and spreading of ixodid ticks, thus enhancing their role as emerging vectors for pathogenic microorganisms in northern Europe. It remains unclear if they contribute to the occurrence of infections caused by the bacteria Bartonella spp., Francisella tularensis subspecies holarctica and the parasite Toxoplasma gondii in Sweden and on the Åland islands, Finland. In this study, we want to improve understanding of the tick-borne transmission of these pathogens. Volunteers were recruited at primary healthcare centers. Ticks and blood samples were acquired from participants recruited in 2008 and 2009. Health questionnaires were completed, and medical records were acquired where applicable. Feeding time was estimated and screening of pathogens in the ticks was performed through real-time PCR. Ticks (n = 1849) were of mixed developmental stages: 76 larvae, 1295 nymphs, 426 adults and 52 undetermined. All analyzed ticks were considered negative for these pathogens since the CT-values were all below the detection limit for Bartonella spp. (1663 ticks), Francisella spp. (1849 ticks) and Toxoplasma gondii (1813 ticks). We assume that infections with these pathogens are caused by other transmission pathways within these regions of Sweden and the Åland islands, Finland.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.